SUNPHARMANSESun Pharmaceutical Industries Limited· PharmaceuticalsMinimalNeutral
Announced Sat, 23 May · 13:45 IST

Sun Pharmaceutical Industries Limited has informed the Exchange about Newspaper Publication of Financial Results for year ended 31 March 2026

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.1%1-day move
₹1840.00
prior close
₹1840.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.2-0.0-0.1+0.1+0.0-2.0-2.7-2.9-3.2-1.9+1.2+7.2
Up moveDown movePending
AI summary

Sun Pharmaceutical Industries Limited informed the exchanges that it published newspaper advertisements on 23 May 2026 (Financial Express in English and Gujarati) containing the Audited Financial Results for Q4 and FY ended 31 March 2026. The results were approved by the Board of Directors on 22 May 2026 and filed with the Stock Exchanges under Regulation 33 of the SEBI Listing Regulations. Copies of the clippings were attached as Annexure-A and are also available on the company's website at www.sunpharma.com.

Likely market impact

Routine compliance filing confirming that Sun Pharma's Q4 and FY26 audited financial results were publicly disclosed via newspaper advertisement as required under SEBI regulations. No new financial information was disclosed in this filing; the underlying results had already been filed separately.